Remdesivir for FIP: the injectable prodrug of GS-441524

Short answer: remdesivir (GS-5734) is a prodrug of GS-441524 — the body converts it into the same active molecule that treats FIP. It is usually given by injection, is often used to start treatment (especially in very sick cats), and became the legally available, regulated route to FIP therapy in the UK and Australia.

Remdesivir and GS-441524 are two doors to the same room

This trips people up, so it's worth stating plainly. Remdesivir is not a different treatment competing with GS-441524 — it is a chemical delivery vehicle. Once inside the body, remdesivir is metabolised into GS-441524, which is what actually stalls viral replication. If you understand how GS-441524 works, you understand how remdesivir works.

Why bother with the prodrug form, then? Regulatory and practical reasons. Remdesivir was developed and manufactured to pharmaceutical standards for human antiviral use, which gave it a legitimate, quality-controlled supply chain — something the GS-441524 market often lacked. That made it the drug that could be prescribed legally where GS-441524 itself could not.

Where it fits in treatment

• Starting treatment. Injectable remdesivir is often used to begin therapy, particularly in cats that are very unwell or not eating, where reliable blood levels matter most.
• Transitioning to oral. A common modern pattern is to start with injectable remdesivir and transition to oral GS-441524 (or molnupiravir) once the cat stabilises — sparing weeks of daily injections. See oral vs injectable evidence.
• The same 84-day arc. Whichever route, the commitment is the full course and the monitoring described in the treatment evidence.

Legality — the key advantage

Remdesivir's regulated origins are why, in the United Kingdom and Australia, compounded remdesivir (and GS-441524) can be prescribed legally by veterinarians. For owners in those countries, this is often the safest route: a known product, a known concentration, and veterinary oversight — the opposite of the unregulated-market quality problem that dogs GS-441524's black-market supply.

Access and rules differ elsewhere and change over time. Ask your vet what is legally available where you live.

Not veterinary advice. Remdesivir dosing and sourcing are decisions for a veterinarian who has examined your cat.

References

1. Coggins S.J. et al. Outcomes of treatment of cats with FIP using remdesivir and GS-441524. Journal of Feline Medicine and Surgery, 2023. Find on PubMed
2. Efficacy of GS-441524 for FIP: a systematic review (2018–2024). Read on PMC